The ACE inhibitors are primarily used in patients with CAD following myocardial infarction, in diabetic patients and patients with left ventricular dysfunction but all other patients with CAD should also receive ACE inhibitors once beta-blocker therapy has been established [18, 33]. The gene discussed is ACE; the disease is coronary artery disorder.